Skip to main content

POINT Biopharma Global Inc.

PNTDelisted Dec 27, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001811764

POINT Biopharma Global Inc. was delisted on Dec 27, 2023; its insiders filed their last Form 4 on Dec 27, 2023; 126 institutions reported holding it in 13F filings for Q3 2023, worth $411.0M in total; no superinvestor held it.

Q3 2021 vs. Q2 2021

How the institutions holding POINT Biopharma Global Inc. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of PNT: Q2 2021 compared with Q3 2021
MeasureQ2 2021Q3 2021Change
Holders034+34
Shares032.2M+32.2M
Value$0$247.7M+$247.7M

New holders (34)

Institutions that held POINT Biopharma Global Inc. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to PNT in Q3 2021
InstitutionSharesValue% of portfolio
Ra Capital Management, L.P.8,856,018$68.1M0.94%
BVF Inc2,772,226$21.3M0.83%
Boxer Capital, LLC2,500,000$19.2M0.67%
Citadel Advisors LLC2,446,365$18.8M0.02%
Farallon Capital Management, L.L.C.2,290,000$17.6M0.09%
Suvretta Capital Management, LLC2,225,000$17.1M0.29%
BlackRock Inc.1,731,106$13.3M0.00%
Vanguard Group Inc1,459,577$11.2M0.00%
Perceptive Advisors LLC1,242,879$9.56M0.14%
Fairmount Funds Management LLC1,099,489$8.46M3.07%
Franklin Resources Inc1,000,000$7.69M0.00%
Johnson & Johnson1,000,000$7.69M0.67%
Alyeska Investment Group, L.P.821,022$6.31M0.08%
Sphera Funds Management Ltd.739,190$5.68M0.56%
Geode Capital Management, LLC511,618$3.93M0.00%
RTW Investments, LP490,000$3.77M0.06%
Berylson Capital Partners, LLC386,221$2.97M1.37%
State Street Corp226,400$1.74M0.00%
Northern Trust Corp129,885$999.0K0.00%
Silverarc Capital Management, LLC71,729$552.0K0.32%
D. E. Shaw & Co., Inc.62,882$484.0K0.00%
Charles Schwab Investment Management Inc29,078$224.0K0.00%
Bank of New York Mellon Corp28,831$222.0K0.00%
Sigma Planning Corp21,865$168.0K0.01%
Claro Advisors LLC15,300$118.0K0.05%
Chicago Partners Investment Group LLC10,295$92.0K0.01%
Victory Capital Management Inc10,544$81.0K0.00%
Point72 Hong Kong Ltd8,241$63.0K0.00%
Wells Fargo & Company7,447$57.0K0.00%
Bank of America Corp5,615$43.0K0.00%
Tower Research Capital LLC (TRC)3,861$30.0K0.00%
Cubist Systematic Strategies, LLC3,637$28.0K0.00%
Morgan Stanley3,485$27.0K0.00%
Royal Bank of Canada3,000$23.0K0.00%

Sold out (0)

Institutions that held POINT Biopharma Global Inc. at the end of Q2 2021 and filed for Q3 2021 without it.

None.